(Monash University) A Monash University research team has shown how PEGylated Polylysine dendrimers, a new type of nano-sized drug delivery system, can be altered to target either the lymphatic system or the bloodstream, which may improve the treatment of particular types of diseases.
Read »Navigation
User login
Visit the BiotechMashup Blog